Literature DB >> 24001437

Metabolic syndrome and right ventricle: an updated review.

Marijana Tadic1, Branislava Ivanovic, Cesare Cuspidi.   

Abstract

The cluster of metabolic and hemodynamic abnormalities which characterize the metabolic syndrome (MS) is responsible for subclinical cardiac and extra-cardiac damage such as left ventricular hypertrophy, diastolic dysfunction, carotid atherosclerosis and microalbuminuria. The development of different non-invasive imaging methods enabled a detail investigation of right ventricular structure and function, and revealed that right ventricular remodeling followed changes in the left ventricular structure and function in patients with arterial hypertension, diabetes or obesity. Previous investigations also reported that the coexistence of two components of the MS induced more significant cardiac remodeling than the presence of only one MS risk-factor. The relationship between different components of the MS (increased blood pressure, abdominal obesity, increased fasting glucose level and dyslipidemia) and right ventricular remodeling could be explained by several hemodynamic and non-hemodynamic mechanisms. However, the association between right ventricular remodeling and the MS has not been sufficiently investigated so far. The aim of this article was to review recent articles focusing on the association between metabolic syndrome components and the metabolic syndrome itself with impairments in right ventricular structure and function assessed by different imaging techniques.
© 2013.

Entities:  

Keywords:  CT; Diabetes; Dyslipidemia; HDL-C; HOMA; HbA1c; Hypertension; LV; MET; MR; MS; Metabolic syndrome; Obesity; RAAS; RV; Right ventricle; SPECT; TAPSE; computed tomography; glycosylated hemoglobin; high-density lipoprotein cholesterol; homeostasis model assessment; left ventricle; magnetic resonance; metabolic equivalent; metabolic syndrome; renin–angiotensin–aldosterone system; right ventricle; single photon emission computed tomography; tricuspid annular plane systolic excursion

Mesh:

Year:  2013        PMID: 24001437     DOI: 10.1016/j.ejim.2013.08.007

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  11 in total

1.  Serum uric acid and its relationship with cardiovascular risk profile in Chinese patients with early-onset coronary artery disease.

Authors:  Xiao-Min Dai; Lei Wei; Li-Li Ma; Hui-Yong Chen; Zhuo-Jun Zhang; Zong-Fei Ji; Wan-Long Wu; Ling-Ying Ma; Xiu-Fang Kong; Lin-Di Jiang
Journal:  Clin Rheumatol       Date:  2015-01-29       Impact factor: 2.980

Review 2.  Efficacy of prenatal diagnosis of major congenital heart disease on perinatal management and perioperative mortality: a meta-analysis.

Authors:  Yi-Fei Li; Kai-Yu Zhou; Jie Fang; Chuan Wang; Yi-Min Hua; De-Zhi Mu
Journal:  World J Pediatr       Date:  2016-04-08       Impact factor: 2.764

3.  Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients.

Authors:  Angela Sciacqua; Maria Perticone; Sofia Miceli; Angelina Pinto; Velia Cassano; Elena Succurro; Francesco Andreozzi; Marta Letizia Hribal; Giorgio Sesti; Francesco Perticone
Journal:  Endocrine       Date:  2019-02-21       Impact factor: 3.633

4.  Comprehensive assessment of biventricular myocardial function by two-dimensional speckle tracking echocardiography in infants of gestational diabetic mothers.

Authors:  Andrea Sonaglioni; Marta Braga; Maria Cristina Villa; Anna Ferrulli; Gian Luigi Nicolosi; Michele Lombardo; Claudio Migliori; Livio Luzi
Journal:  Acta Diabetol       Date:  2022-06-09       Impact factor: 4.087

5.  Right ventricle free wall mechanics in metabolic syndrome without type-2 diabetes: effects of a 3-month lifestyle intervention program.

Authors:  Juan Serrano-Ferrer; Guillaume Walther; Edward Crendal; Agnès Vinet; Frédéric Dutheil; Geraldine Naughton; Bruno Lesourd; Robert Chapier; Daniel Courteix; Philippe Obert
Journal:  Cardiovasc Diabetol       Date:  2014-08-03       Impact factor: 9.951

6.  Markers of maternal and infant metabolism are associated with ventricular dysfunction in infants of obese women with type 2 diabetes.

Authors:  W Todd Cade; Philip T Levy; Rachel A Tinius; Mehgna D Patel; Swati Choudhry; Mark R Holland; Gautam K Singh; Alison G Cahill
Journal:  Pediatr Res       Date:  2017-06-28       Impact factor: 3.756

7.  Cardiac magnetic resonance feature tracking for quantifying right ventricular deformation in type 2 diabetes mellitus patients.

Authors:  Bi-Yue Hu; Jin Wang; Zhi-Gang Yang; Yan Ren; Li Jiang; Lin-Jun Xie; Xi Liu; Yue Gao; Meng-Ting Shen; Hua-Yan Xu; Ke Shi; Zhen-Lin Li; Chun-Chao Xia; Wan-Lin Peng; Ming-Yan Deng; Hong Li; Ying-Kun Guo
Journal:  Sci Rep       Date:  2019-07-31       Impact factor: 4.379

8.  Metabolic risk factors of cognitive impairment in young women with major psychiatric disorder.

Authors:  Chuanjun Zhuo; Wei Liu; Ronghuan Jiang; Ranli Li; Haiping Yu; Guangdong Chen; Jianmin Shan; Jingjing Zhu; Ziyao Cai; Chongguang Lin; Langlang Cheng; Yong Xu; Sha Liu; Qinghua Luo; Shili Jin; Chuanxin Liu; Jiayue Chen; Lina Wang; Lei Yang; Qiuyu Zhang; Qianchen Li; Hongjun Tian; Xueqin Song
Journal:  Front Psychiatry       Date:  2022-07-29       Impact factor: 5.435

9.  Pericardial Fat and Right Ventricular Morphology: The Multi-Ethnic Study of Atherosclerosis- Right Ventricle Study (MESA-RV).

Authors:  David S Wenger; Steven M Kawut; Jingzhong Ding; David A Bluemke; Catherine L Hough; Richard A Kronmal; Joao A Lima; Peter J Leary
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

10.  Metabolic syndrome agravates cardiovascular, oxidative and inflammatory dysfunction during the acute phase of Trypanosoma cruzi infection in mice.

Authors:  Bruno Fernando Cruz Lucchetti; Natalia Boaretto; Fernanda Novi Cortegoso Lopes; Aparecida Donizette Malvezi; Maria Isabel Lovo-Martins; Vera Lúcia Hideko Tatakihara; Victor Fattori; Rito Santo Pereira; Waldiceu Aparecido Verri; Eduardo Jose de Almeida Araujo; Phileno Pinge-Filho; Marli Cardoso Martins-Pinge
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.